Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 3/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.37 |
| ▸ | NPC1 | O15118 | 1/20 | 0.37 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
| ▸ | RECQL | P46063 | 1/20 | 0.37 |
| ▸ | RAB9A | P51151 | 1/20 | 0.37 |
| ▸ | TSHR | P16473 | 3/20 | 0.36 |
| ▸ | ADORA3 | P0DMS8 | 3/20 | 0.36 |
| ▸ | ADORA2A | P29274 | 2/20 | 0.36 |
| ▸ | ADORA2B | P29275 | 2/20 | 0.36 |
| ▸ | ADORA1 | P30542 | 2/20 | 0.36 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.35 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.35 |
| ▸ | ATM | Q13315 | 2/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | TP53 | P04637 | 1/20 | 0.35 |
| ▸ | HPGD | P15428 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20405146 | 0.84 | MAPT (0.35) | MAPTSMN1; SMN2NPC1LMNARECQL | |
| SCHEMBL18819551 | 0.81 | MAPT (0.35) | MAPTSMN1; SMN2NPC1LMNARECQL | |
| SCHEMBL23654767 | 0.80 | TSHR (0.32) | TSHRMAPK1HSD17B10 | |
| SCHEMBL20404986 | 0.79 | L3MBTL1 (0.35) | MAPTSMN1; SMN2NPC1LMNARECQL | |
| SCHEMBL20405083 | 0.78 | WDR5 (0.41) | MAPTSMN1; SMN2NPC1LMNARECQL | |
| SCHEMBL18819259 | 0.77 | PTGS2 (0.39) | MAPTSMN1; SMN2LMNATSHRADORA3 | |
| SCHEMBL20404952 | 0.77 | TSHR (0.43) | MAPTSMN1; SMN2LMNATSHRADORA3 | |
| SCHEMBL20405029 | 0.77 | ADORA2A (0.43) | MAPTSMN1; SMN2NPC1LMNARAB9A | |
| SCHEMBL18821455 | 0.76 | ADORA1 (0.37) | MAPTSMN1; SMN2LMNATSHRADORA3 | |
| SCHEMBL22056861 | 0.76 | MAPT (0.33) | MAPTSMN1; SMN2NPC1LMNARECQL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11737357-B2 | Compound and organic light-emitting device comprising same | LG CHEM, LTD. | 2023-08-22 | — | — | US | disclosed |
| US-11737357-B2 | Compound and organic light-emitting device comprising same | LG CHEM, LTD. | 2023-08-22 | — | — | US | disclosed |
| EP-3351536-B1 | ORGANIC LIGHT-EMITTING DEVICE | LG CHEMICAL LTD (KR) | 2021-07-21 | — | — | EP | disclosed |
| US-10367149-B2 | Organic light-emitting device | LG CHEM, LTD. (KR) | 2019-07-30 | — | — | US | disclosed |
| US-20190055222-A1 | COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME | LG CHEM, LTD. (KR) | 2019-02-21 | — | — | US | disclosed |
| EP-3351536-A1 | ORGANIC LIGHT-EMITTING DEVICE | LG Chem, Ltd. (KR) | 2018-07-25 | — | — | EP | disclosed |
| EP-3351537-A1 | COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME | LG Chem, Ltd. (KR) | 2018-07-25 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11737357-B2 | Compound and organic light-emitting device comprising same | CRY1, CYP1B1, CYP1A1 | MAPT 1315/4885SMN1; SMN2 4315/4885NPC1 756/4885 |
| US-10367149-B2 | Organic light-emitting device | CRY1, PPOX, CRY2 | MAPT 774/4885SMN1; SMN2 4182/4885NPC1 3017/4885 |
| US-20190055222-A1 | COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME | CRY1, CYP1B1, CYP1A1 | MAPT 1315/4885SMN1; SMN2 4315/4885NPC1 756/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.